Answers are grounded in this paper and cite their sources.
Evaluates CPK levels as a biomarker for organophosphate poisoning severity, suggesting potential use in clinical settings.
Organophosphorus (OP) poisoning is a significant public health problem, particularly in developing countries, and there is a need for accessible biomarkers. This paper evaluates the study entitled “Serum Creatine Phosphokinase as a Biomarker in Organophosphorus Poisoning.” The study's strengths include the correlation between serum creatine phosphokinase (CPK) levels and poisoning severity, and its cost-effectiveness as a test. However, the limited sample size and the small number of patients in the severe poisoning group limit the generalizability of the results. Furthermore, the specificity issues of CPK and concomitant clinical conditions that may affect its levels should be considered. In conclusion, while CPK is a promising biomarker in OP poisoning, more comprehensive studies are needed to clarify its clinical use.
No takes yet. Share an insight, caveat, or question.
Mürsel Koçer (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: